Copeland Capital Management LLC Has $18.75 Million Holdings in U.S. Physical Therapy, Inc. (USPH)

Copeland Capital Management LLC decreased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 15.5% during the third quarter, HoldingsChannel.com reports. The fund owned 158,086 shares of the company’s stock after selling 29,100 shares during the quarter. U.S. Physical Therapy comprises about 1.1% of Copeland Capital Management LLC’s investment portfolio, making the stock its 25th biggest holding. Copeland Capital Management LLC’s holdings in U.S. Physical Therapy were worth $18,749,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of the business. Oppenheimer Asset Management Inc. raised its holdings in U.S. Physical Therapy by 10.4% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 5,870 shares of the company’s stock valued at $697,000 after acquiring an additional 554 shares during the period. Victory Capital Management Inc. raised its holdings in U.S. Physical Therapy by 2.8% during the 2nd quarter. Victory Capital Management Inc. now owns 21,790 shares of the company’s stock valued at $2,092,000 after acquiring an additional 590 shares during the period. Comerica Bank raised its holdings in U.S. Physical Therapy by 5.0% during the 2nd quarter. Comerica Bank now owns 13,909 shares of the company’s stock valued at $1,413,000 after acquiring an additional 665 shares during the period. BlueMountain Capital Management LLC raised its holdings in U.S. Physical Therapy by 54.3% during the 2nd quarter. BlueMountain Capital Management LLC now owns 2,691 shares of the company’s stock valued at $258,000 after acquiring an additional 947 shares during the period. Finally, PNC Financial Services Group Inc. raised its holdings in U.S. Physical Therapy by 62.7% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,676 shares of the company’s stock valued at $256,000 after acquiring an additional 1,031 shares during the period. 97.61% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Mark J. Brookner sold 2,500 shares of the business’s stock in a transaction on Friday, September 21st. The shares were sold at an average price of $116.00, for a total transaction of $290,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Clayton Trier sold 1,250 shares of the business’s stock in a transaction on Friday, August 17th. The shares were sold at an average price of $115.50, for a total transaction of $144,375.00. The disclosure for this sale can be found here. Insiders have sold a total of 22,750 shares of company stock valued at $2,642,402 over the last 90 days. Company insiders own 2.50% of the company’s stock.

A number of equities research analysts have issued reports on USPH shares. Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Zacks Investment Research raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 target price on the stock in a report on Tuesday, August 7th. Jefferies Financial Group restated a “hold” rating and set a $105.00 price target on shares of U.S. Physical Therapy in a research report on Friday, August 3rd. Finally, Cantor Fitzgerald boosted their price target on shares of U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research report on Friday. Four analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $113.67.

USPH opened at $113.00 on Friday. The firm has a market cap of $1.43 billion, a PE ratio of 46.69, a PEG ratio of 3.98 and a beta of 1.19. The company has a quick ratio of 2.06, a current ratio of 1.93 and a debt-to-equity ratio of 0.26. U.S. Physical Therapy, Inc. has a one year low of $64.45 and a one year high of $129.65.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, November 1st. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.06. The firm had revenue of $113.10 million during the quarter, compared to analyst estimates of $112.79 million. U.S. Physical Therapy had a net margin of 5.58% and a return on equity of 17.64%. U.S. Physical Therapy’s revenue for the quarter was up 9.8% compared to the same quarter last year. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.54 EPS for the current fiscal year.

The company also recently declared a dividend, which will be paid on Friday, December 7th. Stockholders of record on Friday, November 9th will be given a dividend of $0.23 per share. The ex-dividend date is Thursday, November 8th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 44.23%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More: How Investors Use a Balance Sheet

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply